Arcturus Therapeutics Holdings Inc. Common Stock
$15.84
$0.55 (+3.60%)
$14.76Day Range$15.99
Key Statistics
Market Cap
$450.22M
Shares Outstanding
28.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 22, 2013
Round Lot
100
Locale
US
Trading Data
Day Open
$15.34
Day High
$15.99
Day Low
$14.76
Volume
556.2K
VWAP
$15.59
Prev Close
$15.29
Transactions
--
Acc. Volume
--
About Arcturus Therapeutics Holdings Inc. Common Stock
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
PHARMACEUTICAL PREPARATIONSSIC 2834111 employees10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA(858) 900-2660IPO May 22, 2013US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001768224
- Composite FIGI
- BBG00NNW8JK1
- Share Class FIGI
- BBG00NNW8JL0
- Ticker Root
- ARCT
- SIC Code
- 2834
About Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) closed the 2026-09-15 session at $15.84, up 3.60% versus the previous close (+0.55). The stock opened at $15.34 and traded between $14.76 and $15.99 during that session. Session trading volume was 556K shares. The volume-weighted average price (VWAP) is $15.59.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Arcturus Therapeutics Holdings Inc. Common Stock has a market capitalization of $450.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ARCT is listed on the XNAS exchange. The company employs approximately 111 people. Arcturus Therapeutics Holdings Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2013-05-22.
On this page you can find market ARCT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.